Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Ophthalmology

Long-Term Monitoring and Systemic Risk Management

At a Glance

Long-term diabetic retinopathy care depends on more than eye treatments: managing blood sugar, blood pressure, cholesterol, smoking, and kidney health, while keeping the right exam schedule, can help slow progression. Extra monitoring may be needed during pregnancy or rapid glucose changes.

While treatments like injections and lasers manage the damage inside your eyes, the long-term health of your vision is deeply tied to what happens in the rest of your body. Diabetic retinopathy is a systemic disease. Managing your blood sugar, blood pressure, cholesterol, and kidney health is the most powerful way to slow or even stop the progression of the disease [1][2].

Systemic Risk Factors

Your HbA1c (a measure of your average blood sugar over three months) is one of the most important modifiable risk factors for retinopathy progression. High levels of blood sugar cause the oxidative stress that weakens retinal vessels [3]. Research consistently shows that intensive blood sugar control reduces the risk of developing severe retinopathy over time [4][5].

Additionally, high blood pressure (hypertension) puts extra physical strain on the weakened blood vessels in your eyes, increasing the risk of leakage [6][7]. Managing lipids/cholesterol and stopping smoking are also important steps to protect your vascular health. Work with your primary diabetes team to set individualized targets for these metrics; do not alter medications without their guidance.

The “Early Worsening” Phenomenon

It is important to know that if your blood sugar is very high and is lowered very rapidly (such as when starting an insulin pump or intensive new medication), your retinopathy can actually appear to get worse for a period of time [8][9]. This early worsening is a known risk, but it is not a reason to delay needed diabetes treatment. Instead, it means you should coordinate with your eye doctor for a baseline assessment and careful monitoring during this transition [5].

The Eye-Kidney Connection

The tiny vessels in your eyes are very similar to the tiny filters in your kidneys. If you have signs of kidney damage, such as protein in your urine (albuminuria) or a low eGFR, you are at a much higher risk for progressive retinopathy [10][11]. Your eye doctor and primary care team should coordinate closely if you have diabetic kidney disease [10].

Pregnancy and Retinopathy

Pregnancy is a time of high metabolic demand that can cause pre-existing diabetic retinopathy to progress rapidly [12]. If you have Type 1 or Type 2 diabetes and are planning pregnancy, you should coordinate with ophthalmology, diabetes care, and obstetrics. Guidelines commonly recommend a baseline eye exam before conception or in the first trimester, with follow-up tailored to the severity of the retinopathy (sometimes very frequent monitoring is needed). Note: Retinopathy is rare in people who only develop gestational diabetes during pregnancy [13].

Recommended Screening Intervals

Your screening schedule is individualized based on the current health of your retina and how stable your systemic health is [14]. Guidelines suggest illustrative ranges, but your clinician will adjust these based on your specific situation (such as the presence of DME, pregnancy, or rapid glucose changes):

  • No Retinopathy: Often every 1–2 years [15]
  • Mild NPDR: Typically every 12 months [14]
  • Moderate NPDR: Generally every 3–6 months [14]
  • Severe NPDR: Generally every 2–4 months (or sooner) [14]
  • Proliferative (PDR): Requires active specialist follow-up; visits may be every 1–3 months or more frequently depending on treatment status.

Managing your eyes is a lifelong commitment, and consistent monitoring is the best way to ensure you stay on the path to clear vision.

Common questions in this guide

How do blood sugar levels and HbA1c affect diabetic retinopathy?
HbA1c reflects your average blood sugar over about three months, and higher levels are linked with a greater risk of retinopathy progression. Improving blood sugar control can reduce the risk of severe eye disease, but your target should be individualized with your diabetes care team.
Can diabetic retinopathy get worse after blood sugar drops quickly?
Yes. When very high blood sugar is lowered rapidly, retinopathy can temporarily appear to worsen, a phenomenon called early worsening. This is not a reason to delay needed diabetes treatment; your eye doctor can perform a baseline exam and monitor you more closely during the change.
How are kidney problems connected to diabetic retinopathy?
The small blood vessels in the retina and kidneys can be affected by diabetes in similar ways. Albumin in the urine or a low eGFR indicates kidney damage and is associated with a higher risk of progressive retinopathy, so share kidney test results with your eye-care team.
How often should I have eye exams for diabetic retinopathy?
The schedule depends on your retinal findings and overall health. Screening may be every one to two years with no retinopathy, about yearly with mild disease, every three to six months with moderate disease, and every two to four months or more often with severe disease; proliferative disease requires active specialist follow-up.
How should diabetic retinopathy monitoring change during pregnancy?
People with type 1 or type 2 diabetes should have an eye exam before conception or early in the first trimester, followed by visits based on the severity of retinopathy. Ophthalmology, diabetes care, and obstetrics should coordinate because pre-existing retinopathy can progress during pregnancy.
What can I do to protect my vision from diabetic retinopathy?
Work with your care team to manage blood sugar, blood pressure, cholesterol, kidney health, and smoking, while keeping every recommended eye appointment. Do not change diabetes or blood pressure medicines on your own, and tell your eye doctor about major treatment changes, kidney results, or a planned pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my current health factors, what is my individual risk of my retinopathy progressing?
  2. 2.If we are planning to lower my blood sugar quickly, do I need to schedule an eye exam to monitor for 'early worsening'?
  3. 3.What are my target blood pressure and cholesterol numbers to help protect the small vessels in my eyes?
  4. 4.How often should I have my kidneys checked to help monitor my overall risk for vision loss?
  5. 5.If I am planning a pregnancy, how should my eye exam schedule change before and during the pregnancy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Associations between diabetic retinopathy and systemic risk factors.

    Wat N, Wong RL, Wong IY

    Hong Kong medical journal = Xianggang yi xue za zhi 2016; (22(6)):589-99 doi:10.12809/hkmj164869.

    PMID: 27779095
  2. 2

    Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy.

    Mamtora S, Sandinha T, Carey PE, Steel DHW

    Ophthalmology and therapy 2017; (6(1)):105-114 doi:10.1007/s40123-016-0069-z.

    PMID: 27858333
  3. 3

    Quantification of risk factors for diabetic retinopathy progression.

    Tarasewicz D, Conell C, Gilliam LK, Melles RB

    Acta diabetologica 2023; (60(3)):363-369 doi:10.1007/s00592-022-02007-6.

    PMID: 36527502
  4. 4

    Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.

    Hainsworth DP, Bebu I, Aiello LP, et al.

    Diabetes care 2019; (42(5)):875-882 doi:10.2337/dc18-2308.

    PMID: 30833368
  5. 5

    Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control.

    Lam PY, Chow SC, Lam WC, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):2767-2785 doi:10.2147/OPTH.S301317.

    PMID: 34234400
  6. 6

    Blood pressure control for diabetic retinopathy.

    Do DV, Han G, Abariga SA, et al.

    The Cochrane database of systematic reviews 2023; (3()):CD006127 doi:10.1002/14651858.CD006127.pub3.

    PMID: 36975019
  7. 7

    Sight-threatening diabetic retinopathy and its predictors among patients with diabetes visiting Adare General Hospital in Southern Ethiopia: a hospital-based cross-sectional study.

    Alemayehu HB, Tilahun MM, Abebe MG, Tegegn MT

    BMJ open 2024; (14(2)):e077552 doi:10.1136/bmjopen-2023-077552.

    PMID: 38387987
  8. 8

    Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes.

    Feldman-Billard S, Larger É, Massin P,

    Diabetes & metabolism 2018; (44(1)):4-14 doi:10.1016/j.diabet.2017.10.014.

    PMID: 29217386
  9. 9

    Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review.

    Akil H, Burgess J, Nevitt S, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2022; (13(1)):1-23 doi:10.1007/s13300-021-01190-z.

    PMID: 34928488
  10. 10

    Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.

    Rajalakshmi R, Shanthi Rani CS, Venkatesan U, et al.

    BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2020-001325.

    PMID: 32475840
  11. 11

    Diabetic retinopathy and kidney involvement in adults with type 2 diabetes in high-altitude Tibet: A cross-sectional subanalysis of the China National Diabetic Chronic Complications Study.

    Yang L, Zhang Z

    The Journal of international medical research 2026; (54(4)):3000605261437612 doi:10.1177/03000605261437612.

    PMID: 41954188
  12. 12

    Adherence to the recommended diabetic retinopathy screening guidelines in pregnant women with pregestational diabetes: a cross-sectional survey study.

    Widyaputri F, Rogers SL, Nankervis AJ, et al.

    BMJ open 2025; (15(9)):e099917 doi:10.1136/bmjopen-2025-099917.

    PMID: 41027701
  13. 13

    Diabetic Retinopathy-A Review.

    Pushparani DS, Varalakshmi J, Roobini K, et al.

    Current diabetes reviews 2025; (21(7)):43-55 doi:10.2174/0115733998296228240521151050.

    PMID: 38831577
  14. 14

    Evidence-based Danish guidelines for screening of diabetic retinopathy.

    Grauslund J, Andersen N, Andresen J, et al.

    Acta ophthalmologica 2018; (96(8)):763-769 doi:10.1111/aos.13936.

    PMID: 30311394
  15. 15

    Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II.

    Drinkwater JJ, Davis TME, Turner AW, Davis WA

    Diabetic medicine : a journal of the British Diabetic Association 2023; (40(4)):e15032 doi:10.1111/dme.15032.

    PMID: 36537852

This page explains long-term diabetic retinopathy monitoring and systemic risk factors for informational purposes only and does not constitute medical advice. Ask your eye doctor and diabetes care team to create an individualized screening and treatment plan.

Get notified when new evidence is published on diabetic retinopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.